Cell Specific Gene Expression
What is Gene Expression?
What is Gene Expression?
Chromatin Position Affects Gene Expression
Functional Groups
Expressing Solution Concentration
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 10, 2026

Establishment and Genetic Manipulation of Murine Hepatocyte Organoids
Published on: February 12, 2022
Takashi Kojima1, Norimasa Sawada
1Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan. ktakashi@sapmed.ac.jp
This study explores how TGF-β affects tight junction proteins in liver cells during a process called epithelial-mesenchymal transition. The researchers focused on claudin-1, claudin-2, and occludin, which are important for maintaining the blood-biliary barrier. They found that TGF-β reduces claudin-1 levels and increases claudin-2 levels in liver cells. These changes suggest a disruption in the barrier function of tight junctions. The study used rat liver cells and examined how TGF-β alters protein expression and localization. The findings indicate that cytokine signaling modifies liver cell barriers, which may contribute to liver disease progression.
Area of Science:
Background:
Tight junctions in hepatocytes are essential for maintaining the blood-biliary barrier. Prior research has shown that these junctions prevent bile from mixing with blood. However, it was unclear how cytokines and growth factors regulate tight junction proteins. No prior work had resolved how TGF-β influences this process. This gap motivated an investigation into how TGF-β affects tight junctions during epithelial-mesenchymal transition. The role of claudins in this process had not been fully explored. Understanding these changes could clarify how liver cells adapt during disease. The fence function of tight junctions remained an open question in this context.
Purpose Of The Study:
The aim of this study was to examine how TGF-β affects tight junction proteins in hepatocytes during epithelial-mesenchymal transition. The researchers focused on claudin-1, claudin-2, and occludin. They wanted to determine if TGF-β alters the expression or localization of these proteins. The study also aimed to assess the fence function of tight junctions under TGF-β exposure. The motivation was to understand how cytokine signaling modifies liver cell barriers. This could provide insights into liver disease progression. The study sought to clarify whether TGF-β disrupts the barrier function. The findings could help explain how liver cells respond to inflammatory signals.
Main Methods:
The researchers used primary cultures of adult rat hepatocytes to study tight junction changes. They applied TGF-β to induce epithelial-mesenchymal transition. The expression of claudin-1, claudin-2, and occludin was analyzed using immunofluorescence. Localization of these proteins was assessed via confocal microscopy. The study also evaluated the fence function of tight junctions. The effects of TGF-β on protein expression were quantified. The researchers examined whether TGF-β altered protein localization patterns. The study combined molecular and imaging techniques to assess functional changes.
Main Results:
TGF-β treatment led to a decrease in claudin-1 expression in hepatocytes. Claudin-2 levels increased significantly under TGF-β exposure. Occludin expression remained largely unchanged. The localization of claudin-1 shifted from tight junctions to cytoplasmic regions. Claudin-2 redistributed to the cell membrane during EMT. The fence function of tight junctions was compromised after TGF-β treatment. These changes suggest a disruption in the blood-biliary barrier. The study found that TGF-β alters the expression and localization of key tight junction proteins.
Conclusions:
The authors propose that TGF-β induces changes in tight junction proteins during EMT. They suggest that claudin-1 downregulation and claudin-2 upregulation are linked to barrier disruption. The shift in claudin-1 localization may weaken the fence function. The study supports the idea that cytokine signaling modifies liver cell barriers. The findings indicate that TGF-β alters tight junction composition. The researchers conclude that these changes may contribute to liver disease progression. The study highlights the role of claudins in maintaining the blood-biliary barrier. These results suggest that cytokine signaling affects hepatocyte barrier integrity.
The study found that TGF-β induces changes in claudin-1 and claudin-2 expression in hepatocytes during EMT.
The researchers used confocal microscopy to evaluate the localization of claudin-1 and claudin-2 in hepatocytes.
Claudin-1 localization at tight junctions is essential for maintaining the barrier between bile and blood.
TGF-β reduces claudin-1 expression and increases claudin-2 levels in hepatocytes during EMT.
The study used immunofluorescence and confocal microscopy to track protein localization changes.
The findings suggest that TGF-β-induced changes in tight junctions may contribute to liver disease progression.